
Taro Pharmaceutical Industries Investor Relations Material
Latest events

Q4 2024
20 May, 2024

Q3 2024
25 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Taro Pharmaceutical Industries Ltd
Access all reports
Taro Pharmaceutical Industries Ltd is a pharmaceutical company that develops, manufactures, and markets a range of prescription and over-the-counter medications. The company specializes in dermatological products, while also offering treatments in areas such as cardiology, neurology, and anti-inflammatory therapies. Taro focuses on producing generic pharmaceuticals, with a portfolio that includes creams, ointments, tablets, and liquids. Its products are distributed to markets globally, primarily in North America. The company is headquartered in Haifa Bay, Israel, and its shares are listed on the NYSE.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
TARO
Country
🇺🇸 United States